ENGVALL et al. V. DAVID et al. - Page 59




                                        be free of said antigenic substance, to determine the presence of                                  
                                        antigenic substance in said fluid sample, or relating the amount of                                
                                        labeled  antibody  measured  with  the  amount  of  labeled  antibody                              
                                        measured  for  samples  containing  known  amounts  of  antigenic                                  
                                        substance prepared in accordance with steps (a)-(d) to determine the                               
                                        concentration of antigenic substance in said fluid sample.                                         
                                                 19. In an immunometric assay to determine the presence or                                 
                                        concentration  of  an  antigenic  substance  in  a  sample  of  a  fluid                           
                                        comprising forming a ternary complex of a first labeled antibody, said                             
                                        antigenic substance, and a second antibody said second antibody being                              
                                        bound to a solid carrier insoluble in said fluid wherein the presence of                           
                                        the antigenic substance in the samples is determined by measuring                                  
                                        either the amount of labeled antibody bound to the solid carrier or the                            
                                        amount of unreacted labeled antibody, the improvement comprising                                   
                                        employing monoclonal antibodies having an affinity for the antigenic                               
                                        substance of at least about 10  liters/mole for each of said labeled8                                                                
                                        antibody and said antibody bound to a solid carrier.           [Emphasis                           
                                        added.]                                                                                            
                                2.      David’s semi-automatic screening assay                                                             
                        Engvall asserts that the David inventors withheld the best mode of practicing their invention.                     
                In particular, Engvall alleges that in order to practice the claimed method, it is necessary to screen                     
                for monoclonal antibodies which have an affinity constant of at least about 10  liters per mole for the8                                         
                antigenic substance of interest .  Engvall points out that David had a semi-automatic assay for                            
                performing this function when the David application was filed, that David acknowledged that the                            
                semi-automatic screening assay was the best approach to the screening procedure, and that David’s                          
                specification did not disclose this semi-automatic technique.  Engvall further alleges that David’s                        
                disclosed a different less advantageous technique and that David desired to keep the semi-automatic                        
                assay technique a trade secret shows an intent to conceal the best mode.  Engvall Brief, pp. 122-125.                      
                                3.      Analysis                                                                                           
                        The first paragraph of 35 U.S.C. § 112 provides:                                                                   
                                        The specification shall contain a written description of the invention,                            
                                        and of the manner and process of making and using it, in such full,                                
                                        clear, concise, and exact terms as to enable any person skilled in the                             
                                        art to which it pertains, or with which it is most nearly connected, to                            
                                        make  and  use  the  same,  and shall  set  forth  the  best  mode                                 


                                                                    56                                                                     





Page:  Previous  52  53  54  55  56  57  58  59  60  61  62  63  64  65  66  Next 

Last modified: November 3, 2007